CalciMedica Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CalciMedica Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10878
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CalciMedica Inc (CalciMedica) is a pharmaceutical company that develops small molecule drugs for the treatment of acute and chronic inflammatory and autoimmune disorders and organ transplant rejection. The company’s CM2489 is a compound developed to treat moderate plaque psoriasis. It also identifies CRAC channel inhibitors that are used in animal models of immune disease. The company develops products for the treatment of Alzheimer’s disease and autoimmune diseases including rheumatoid arthritis, psoriasis, lupus, acute pancreatitis, Crohn’s disease and type I diabetes, among others. CalciMedica is headquartered in La Jolla, California, the US.

CalciMedica Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CalciMedica Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CalciMedica Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Calcimedica Raises Us$2.5 Million In Venture Financing 10
CalciMedica Raises US$3 Million In Venture Financing 11
CalciMedica Raises US$4.6 Million In Venture Financing 12
CalciMedica Raises US$13.2 Million In Venture Financing 13
CalciMedica Inc – Key Competitors 14
CalciMedica Inc – Key Employees 15
CalciMedica Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product Approvals 17
May 24, 2017: CalciMedica Receives Fast-Track Designation for CM4620, a Novel CRAC Channel Inhibitor to Treat Acute Pancreatitis 17
Clinical Trials 18
Jan 05, 2017: CalciMedica Initiates Phase 1 Clinical Studies for CRAC Channel Inhibitor 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
CalciMedica Inc, Pharmaceuticals & Healthcare, Key Facts 2
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CalciMedica Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CalciMedica Inc, Deals By Therapy Area, 2012 to YTD 2018 8
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Calcimedica Raises Us$2.5 Million In Venture Financing 10
CalciMedica Raises US$3 Million In Venture Financing 11
CalciMedica Raises US$4.6 Million In Venture Financing 12
CalciMedica Raises US$13.2 Million In Venture Financing 13
CalciMedica Inc, Key Competitors 14
CalciMedica Inc, Key Employees 15

List of Figures
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CalciMedica Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HubSpot, Inc.:企業のM&A・事業提携・投資動向
    HubSpot, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HubSpot, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • J.W. Ostendorf Gmbh & Co Kg:企業の戦略・SWOT・財務分析
    J.W. Ostendorf Gmbh & Co Kg - Strategy, SWOT and Corporate Finance Report Summary J.W. Ostendorf Gmbh & Co Kg - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Allscripts Healthcare Solutions Inc (MDRX):企業の財務・戦略的SWOT分析
    Allscripts Healthcare Solutions Inc (MDRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Exillon Energy Plc (EXI):企業の財務・戦略的SWOT分析
    Summary Exillon Energy Plc (Exillon) is an oil exploration and production company. The company explores, produces and develops crude oil. Its services include drilling, exploration, appraisal, development, operations, management, and production services. Exillon’s operating assets are located in two …
  • Berry Global Group, Inc.:企業の戦略・SWOT・財務情報
    Berry Global Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Berry Global Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Development Center for Biotechnology-製薬・医療分野:企業M&A・提携分析
    Summary Development Center for Biotechnology (DCB) is a non-profit organization that provides support to biotechnology and pharmaceutical companies. The organization develops biotech industry through its cooperation and industrialization, key technologies, infrastructure building, research and devel …
  • Xtant Medical Holdings Inc (XTNT)-医療機器分野:企業M&A・提携分析
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings, Inc. is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteow …
  • SomaLogic Inc:企業の製品パイプライン分析
    Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the pr …
  • ADDvise Group AB (ADDV A):医療機器:M&Aディール及び事業提携情報
    Summary ADDvise Group AB (ADDvise), formerly ADDvise Lab Solutions AB, is a medical device company that manufactures and markets healthcare and laboratory equipment. The company offers laboratory products such as laboratory equipments, furnishings, safety ventilation, centrifuges, climate chambers, …
  • Cerus Corp (CERS)-医療機器分野:企業M&A・提携分析
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • Freudenberg & Co KG:企業の戦略的SWOT分析
    Freudenberg & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Oncolys BioPharma Inc (4588):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncolys BioPharma Inc (Oncolys) is a biotechnology company that discovers and develops treatments for cancer and infectious diseases. The company import and export products including drugs and medicines, oncolytic viruses, pharmaceutical pipeline products and tumor diagnostic agents, among o …
  • TDC A/S:企業のM&A・事業提携・投資動向
    TDC A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TDC A/S Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Westwater Resources, Inc.:企業の戦略・SWOT・財務情報
    Westwater Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Westwater Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • AMVIG Holdings Ltd.:企業の戦略・SWOT・財務情報
    AMVIG Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary AMVIG Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Takara Bio Inc (4974)-医療機器分野:企業M&A・提携分析
    Summary Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments. The company sells gene amplification system and offers scientific instruments. Takara also provides contract res …
  • Pulmagen Therapeutics LLP:製薬・医療:M&Aディール及び事業提携情報
    Summary Pulmagen Therapeutics LLP (Pulmagen) formerly Argenta Discovery Ltd, is a development stage pharmaceutical company, which develops oral and inhaled medicines for chronic respiratory diseases. The company’s product pipeline includes oral CRTh2 antagonists, inhaled bronchodilators, inhaled per …
  • Otto Bock HealthCare GmbH-医療機器分野:企業M&A・提携分析
    Summary Otto Bock HealthCare GmbH (Otto Bock), a group company of Otto Bock Holding GmbH & Co. KG, is a medical device company that manufactures and distributes prosthetic and orthotic devices. It also offers mobility and seating solutions for the physically disabled adults and children. The product …
  • VTB Bank:企業の戦略・SWOT・財務情報
    VTB Bank - Strategy, SWOT and Corporate Finance Report Summary VTB Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Vulcan Minerals Inc (VUL):企業の財務・戦略的SWOT分析
    Summary Vulcan Minerals Inc (Vulcan) is an oil and gas exploration company. The company acquires and develops petroleum and natural gas properties. The company's Springdale project consist all the properties on the Springdale peninsula and operates the Colchester, Pine Pond and Little Bay Mine proje …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆